Prevalence of Histoplasmosis among Persons with Advanced HIV Disease, Nigeria
Supporting Files
Public Domain
-
11 2022
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:Oladele, Rita O. ; Osaigbovo, Iriagbonse I. ; Akanmu, Alani S. ; Adekanmbi, Olukemi A. ; Ekeng, Bassey E. ; Mohammed, Yahaya ; Alex-Wele, Mary A. ; Okolo, Mark O. ; Ayanbeku, Stephen T. ; Unigwe, Uchechukwu S. ; Akase, Iorhen E. ; Dan-Jumbo, Alali ; Isralski, Dennis ; Denning, David W. ; Pasqualotto, Alessandro C. ; Chiller, Tom
-
Description:We sought to determine the prevalence of probable disseminated histoplasmosis among advanced HIV disease (AHD) patients in Nigeria. We conducted a cross-sectional study in 10 sites across 5 of 6 geopolitical zones in Nigeria. We identified patients with urinary samples containing CD4 cell counts <200 cells/mm| or World Health Organization stage 3 or 4 disease who also had >2 clinical features of disseminated histoplasmosis, and we tested them for Histoplasma antigen using a Histoplasma enzyme immune assay. Of 988 participants we recruited, 76 (7.7%) were antigen-positive. The 76 Histoplasma antigen-positive participants had significantly lower (p = 0.03) CD4 counts; 9 (11.8%) were also co-infected with tuberculosis. Most antigen-positive participants (50/76; 65.8%; p = 0.015) had previously received antiretroviral treatment; 26/76 (34.2%) had not. Because histoplasmosis is often a hidden disease among AHD patients in Nigeria, Histoplasma antigen testing should be required in the AHD package of care.
-
Subjects:
-
Source:Emerg Infect Dis. 2022; 28(11):2261-2269
-
Pubmed ID:36286009
-
Pubmed Central ID:PMC9622240
-
Document Type:
-
Place as Subject:
-
Volume:28
-
Issue:11
-
Collection(s):
-
Main Document Checksum:urn:sha256:549605d48d936baa9e5f68013e5d4e8dffa3af9f5f9e8cac40e729e65d06db14
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases